These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 8003767)
1. Behavior and immune status of MRL mice in the postweaning period. Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767 [TBL] [Abstract][Full Text] [Related]
2. A behavioral profile of autoimmune lupus-prone MRL mice. Sakić B; Szechtman H; Keffer M; Talangbayan H; Stead R; Denburg JA Brain Behav Immun; 1992 Sep; 6(3):265-85. PubMed ID: 1392101 [TBL] [Abstract][Full Text] [Related]
3. Intrathecal antibodies and brain damage in autoimmune MRL mice. Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033 [TBL] [Abstract][Full Text] [Related]
4. Age and lpr dependent induction of increased sensitivity to the toxic effects of lipopolysaccharide and indomethacin in MRL mice: evidence for RES activation during disease progression. Hart DA J Clin Lab Immunol; 1988 Jul; 26(3):129-34. PubMed ID: 3230580 [TBL] [Abstract][Full Text] [Related]
5. Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system. Chun S; McEvilly R; Foster JA; Sakic B Mol Psychiatry; 2008 Nov; 13(11):1043-53. PubMed ID: 17768421 [TBL] [Abstract][Full Text] [Related]
6. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis. Nose M; Nishimura M; Kyogoku M Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373 [TBL] [Abstract][Full Text] [Related]
7. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice. Ratkay LG; Tait B; Tonzetich J; Waterfield JD J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961 [TBL] [Abstract][Full Text] [Related]
9. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009 [TBL] [Abstract][Full Text] [Related]
10. Elevated plus maze behavior, auditory startle response, and shock sensitivity in predisease and in early stage autoimmune disease MRL/lpr mice. Nielsen DM; Crnic LS Brain Behav Immun; 2002 Feb; 16(1):46-61. PubMed ID: 11846440 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic significance of serum components in the development of autoimmune polyarthritis in MRL/Mp mice bearing the lymphoproliferation gene. Itoh J; Nose M; Kyogoku M Am J Pathol; 1991 Sep; 139(3):511-21. PubMed ID: 1887861 [TBL] [Abstract][Full Text] [Related]
12. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus. Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787 [TBL] [Abstract][Full Text] [Related]
13. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice. Schaefer CJ; Wooley PH J Rheumatol; 1999 Oct; 26(10):2215-21. PubMed ID: 10529143 [TBL] [Abstract][Full Text] [Related]
14. Defective neutrophil function in the autoimmune mouse strain MRL/lpr. Potential role of transforming growth factor-beta. Gresham HD; Ray CJ; O'Sullivan FX J Immunol; 1991 Jun; 146(11):3911-21. PubMed ID: 1674521 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune MRL/lpr mice sera contain IgG with interleukin 3-like activity. Ohta Y; Tamura S; Tezuka E; Sugawara M; Imai S; Tanaka H J Immunol; 1988 Jan; 140(2):520-5. PubMed ID: 3257242 [TBL] [Abstract][Full Text] [Related]
16. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice. Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422 [TBL] [Abstract][Full Text] [Related]
17. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. Hess DC; Taormina M; Thompson J; Sethi KD; Diamond B; Rao R; Chamberlain CR; Feldman DS J Rheumatol; 1993 Apr; 20(4):610-7. PubMed ID: 8496852 [TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736 [TBL] [Abstract][Full Text] [Related]
19. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus. Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494 [TBL] [Abstract][Full Text] [Related]
20. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect. Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]